Dna Damage Response - Pharma

Relevant Publications

A Guideline Strategy for Identifying a Viral Gene/Protein Evading Antiviral Innate Immunity.

Issue Release: 2025

Dual activities of a silencing information regulator complex in yeast transcriptional regulation and DNA-damage response.

Issue Release: 2024

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Issue Release: 2024

Cadmium activates the innate immune system through the AIM2 inflammasome.

Issue Release: 2024

The DNA Damage Checkpoint Targets the Kinetochore for Relocation of Collapsed Forks to the Periphery.

Issue Release: 2024

Nono induces Gadd45b to mediate DNA repair.

Issue Release: 2024

Pre-pubertal obesity compromises ovarian oxidative stress, DNA repair and chemical biotransformation.

Issue Release: 2024

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Issue Release: 2024

Metal and metal oxide nanoparticles-induced reactive oxygen species: Phytotoxicity and detoxification mechanisms in plant cell.

Issue Release: 2024

The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.

Issue Release: 2024

Synergistic Effect of Maternal Micronutrient Supplementation on ORFV DNA Vaccine Immune Response in a Pregnant Model.

Issue Release: 2024

Chemo-phosphoproteomic profiling with ATR inhibitors berzosertib and gartisertib uncovers new biomarkers and DNA damage response regulators.

Issue Release: 2024

Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts.

Issue Release: 2024

Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer.

Issue Release: 2024

Topoisomerase I is an evolutionarily conserved key regulator for satellite DNA transcription.

Issue Release: 2024

A prominent role of LncRNA H19 in H. pylori CagA induced DNA damage response and cell malignancy.

Issue Release: 2024

NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype.

Issue Release: 2024

Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.

Issue Release: 2024

High expression of 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) associated with Diquat-induced damage.

Issue Release: 2024

UBE2D3 facilitates NHEJ by orchestrating ATM signalling through multi-level control of RNF168.

Issue Release: 2024

What Are the Challenges of Clinical Trials?

Why is Patient Education Important?

What is Transitional Care?

What Challenges Exist in Patient Education?

What is Geriatric Care in Pharma?

What are the Challenges Faced by Generic Manufacturers?

Why is Geriatric Care Important?

What Causes Adverse Drug Events?

How Do Pharmacists Contribute to Patient Care?

What are the Challenges in Implementing Collaborative Care Models?

Partnered Content Networks

Relevant Topics